National Institute for Health and Clinical Excellence. (2007) Varenicline for smoking cessation. London: NICE. Technology appraisal guidance 123.
| Preview | Title | Contact |
|---|---|---|
![[img]](https://www.drugsandalcohol.ie/style/images/fileicons/application_pdf.png)
|
PDF (Varenicline for smoking cessation)
- Published Version
244kB |
External website: https://pathways.nice.org.uk/pathways/smoking
Guidance:
1.1 Varenicline is recommended within its licensed indications as an option for smokers who have expressed a desire to quit smoking.
1.2 Varenicline should normally be prescribed only as part of a programme of behavioural support.
Item Type
Report
Publication Type
International, Guideline, Report
Drug Type
Tobacco / Nicotine
Intervention Type
Drug therapy, Treatment method
Source
Date
2007
Identification #
Technology appraisal guidance 123
Pages
16 p.
Publisher
NICE
Corporate Creators
National Institute for Health and Clinical Excellence
Place of Publication
London
EndNote
Accession Number
HRB (Electronic Only)
Related (external) link
Subjects
VA Geographic area > Europe > United Kingdom
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
B Substances > Tobacco (cigarette smoking)
HJ Treatment or recovery method > Substance disorder treatment method > Cessation of substance use
HJ Treatment or recovery method > Substance disorder treatment method > Substance disorder drug therapy (pharmacological treatment)
B Substances > Tobacco (cigarette smoking)
HJ Treatment or recovery method > Substance disorder treatment method > Cessation of substance use
Repository Staff Only: item control page